Sfoglia per Autore
Nuclear inositide signaling: An appraisal of phospholipase C beta1 behavior in myelodysplastic and leukemia cells
2007 Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L
Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts
2007 Evangelisti C; Tazzari PL; Riccio M; Fiume R; Hozumi Y; Fala F; Goto K; Manzoli L; Cocco L; Martelli AM
Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells
2007 Martelli AM; Evangelisti C; Billi AM; Manzoli L; Papa V; Cocco L
Role of nuclear PLC and PI3K signaling in the development of cancer
2007 Faenza I; Ramazzotti G; Bavelloni A; Bregoli L; Fiume R; Gaboardi GC; Manzoli L; Matteucci A; Martelli AM; Cocco L
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
2007 Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
2008 Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Martelli AM; Cocco L
Nuclear phospholipase C beta1 and cellular differentiation.
2008 Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martelli AM; Cocco L.
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes
2008 Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation.
2008 Ramazzotti G; Faenza I; Gaboardi GC; Piazzi M; Bavelloni A; Fiume R; Manzoli L; Martelli AM; Cocco L
Multiple roles of phosphoinositide-specific phospholipase C isozymes.
2008 Suh PG; Park JI; Manzoli L; Cocco L; Peak JC; Katan M; Fukami K; Kataoka T; Yun S; Ryu SH
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
2009 Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
2009 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele Baccarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.
2009 Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
2009 Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L.
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia.
2009 A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; L. Manzoli; J.A. McCubrey.
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis
2010 Martelli AM; Chiarini F; Evangelisti C; Grimaldi C; Ognibene A; Manzoli L; Billi AM; McCubrey JA
Nuclear inositide signaling in myelodysplastic syndromes.
2010 Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
2010 Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco
Inositide signaling in the nucleus: From physiology to pathology.
2010 Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G.
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response
2011 C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Nuclear inositide signaling: An appraisal of phospholipase C beta1 behavior in myelodysplastic and leukemia cells | Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L | 2007-01-01 | ADVANCES IN ENZYME REGULATION | - | 1.01 Articolo in rivista | - |
Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts |
Evangelisti C; Tazzari PL; Riccio M; Fiume R; Hozumi Y; Fala F; Goto K; Manzoli L; Cocco L; Mart...elli AM |
2007-01-01 | THE FASEB JOURNAL | - | 1.01 Articolo in rivista | - |
Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells | Martelli AM; Evangelisti C; Billi AM; Manzoli L; Papa V; Cocco L | 2007-01-01 | ACTA BIO-MEDICA DE L'ATENEO PARMENSE | - | 1.01 Articolo in rivista | - |
Role of nuclear PLC and PI3K signaling in the development of cancer | Faenza I; Ramazzotti G; Bavelloni A; Bregoli L; Fiume R; Gaboardi GC; Manzoli L; Matteucci A; Mar...telli AM; Cocco L | 2007-01-01 | FUTURE LIPIDOLOGY | - | 1.01 Articolo in rivista | - |
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. |
Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA...; Cocco L |
2007-01-01 | CURRENT MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Marte...lli AM; Cocco L | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Nuclear phospholipase C beta1 and cellular differentiation. | Faenza I; Bregoli L; Ramazzotti G; Gaboardi G; Follo MY; Mongiorgi S; Billi AM; Manzoli L; Martel...li AM; Cocco L. | 2008-01-01 | FRONTIERS IN BIOSCIENCE | - | 1.01 Articolo in rivista | - |
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes | Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L | 2008-01-01 | - | Elsevier | 2.01 Capitolo / saggio in libro | - |
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. | Ramazzotti G; Faenza I; Gaboardi GC; Piazzi M; Bavelloni A; Fiume R; Manzoli L; Martelli AM; Cocco L | 2008-01-01 | CELLULAR SIGNALLING | - | 1.01 Articolo in rivista | - |
Multiple roles of phosphoinositide-specific phospholipase C isozymes. | Suh PG; Park JI; Manzoli L; Cocco L; Peak JC; Katan M; Fukami K; Kataoka T; Yun S; Ryu SH | 2008-01-01 | BMB REPORTS | - | 1.01 Articolo in rivista | Multiple_roles_of_phosphoinositide-specific_phospholipase_C_isozymes.pdf |
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. |
Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccara...ni M; Martelli AM; Manzoli L; Martinelli G; Cocco L |
2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. |
Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L |
2009-01-01 | - | ELSEVIER | 2.01 Capitolo / saggio in libro | - |
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. | Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martell...i AM; Cocco L. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. | A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; L. Manzoli; J.A. McCubrey. | 2009-01-01 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | - | 1.01 Articolo in rivista | - |
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis | Martelli AM; Chiarini F; Evangelisti C; Grimaldi C; Ognibene A; Manzoli L; Billi AM; McCubrey JA | 2010-01-01 | HISTOLOGY AND HISTOPATHOLOGY | - | 1.01 Articolo in rivista | - |
Nuclear inositide signaling in myelodysplastic syndromes. | Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli ...AM; Cocco L | 2010-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; ...Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
Inositide signaling in the nucleus: From physiology to pathology. | Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G. | 2010-01-01 | - | Elsevier | 2.01 Capitolo / saggio in libro | - |
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; ...L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile